[Neonatal multifocal osteomyelitis caused by Serratia marcescens. 10-year evolution of a case].
Explore the source record for details and available documents.
Child↗
Biomedical subjects
M Díez Enciso
Publications and source records attributed to M Díez Enciso.
[Empyema due to erythromycin-resistant Pneumococcus].
Explore the source record for details and available documents.
Adult↗
In vitro activity of aztreonam, cefotaxime, ceftazidime and imipenem combined with ciprofloxacin against gram-negative bacilli and compared with amikacin combinations against Pseudomonas aeruginosa.
Explore the source record for details and available documents.
Amikacin↗
[Streptococcus pneumoniae meningitis highly resistant to penicillin and untreatable with cefotaxime or chloramphenicol].
Explore the source record for details and available documents.
Cefotaxime↗
In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
IN vitro susceptibilities of 98 isolates of Brucella melitensis to N-formimidoyl thienamycin, tetracycline, co-trimoxazole, rifampin, and cefoxitin were determined. N-Formimidoyl thienamycin showed good activity which was similar to those of tetracycline and rifampin and different from that of the other beta-lactam antibiotic tested (cefoxitin), which showed poor activity. Co-trimoxazole showed good activity.
Anti-Bacterial Agents↗
In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
The in vitro synergistic activity of N-formimidoyl thienamycin and amikacin was determined against gentamicin-resistant enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus. N-Formimidoyl thienamycin showed synergism with amikacin against 19 of the gentamicin-resistant strains, 14 of the 49 strains of S. aureus, and only 1 strain of the 46 P. aeruginosa isolates.
Amikacin↗